Leukemia. Plasmacytic leukemia
Conditions
Interventions
Intervention 1: Prescription of zinc sulphate(PO) in case group byoncologist during chemotherapy protocol with 220mg/kg dosage would be performed. Intervention 2: prescription of Multivitamin drug(PO
Treatment - Drugs
Placebo
Prescription of zinc sulphate(PO) in case group byoncologist during chemotherapy protocol with 220mg/kg dosage would be performed
prescription of Multivitamin drug(PO) in control group by oncologist during chemotherapy protocol and the once daily for patients would be performed
Sponsors
Vice chancellor for research, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 71 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients within range of 18-71 years old hospitalizing in oncology ward of Tabriz shahid ghazi hospital(Tabriz, Iran) undergoing chemotherapy due to leukemia. Exclusion criteria: patients who have other systemic diseases; existence of any oral ulcers or mucositis before the beginning chemotherapy; experience of drug sensitivity.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mucositis. Timepoint: 2& 4 weeks after chemotherapy. Method of measurement: Index of WHO. | — |
Secondary
| Measure | Time frame |
|---|---|
| Allergy to drug. Timepoint: One day after drug prescription for one month. Method of measurement: Clinical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNarges Gholizadeh
Tabriz University of Medical Sciences
Outcome results
None listed